Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Renal and cardiac assessment of living kidney donor candidates

Key Points

  • The medical assessment of living kidney donor candidates can include additional investigations beyond the minimal recommended requirements to select candidates at lowest risk of renal and cardiac complications following donation

  • Measured glomerular filtration rate by isotopic methods provides a more accurate assessment of renal function than calculations of estimated glomerular filtration rate (eGFR), but might not be necessary for a large proportion of donor candidates who have acceptable eGFR values

  • Persistent isolated microscopic haematuria should be investigated to exclude urologic and glomerular diseases and might reveal abnormalities that would preclude donation

  • Donor candidates who are at low risk of perioperative cardiac events following nephrectomy do not need to undergo additional cardiac assessment

Abstract

Living kidney donation provides the best therapeutic outcomes for eligible patients with end-stage renal disease. To ensure suitability for living kidney donation, donor candidates undergo a thorough medical, surgical, and psychosocial evaluation by a multidisciplinary transplant assessment team. Numerous guidelines are available to assist clinicians in the process of donor evaluation and selection. These guidelines outline the minimum recommended requirements for donor screening and additional tests that are indicated when abnormalities arise; however, evidence suggests that some of these additional tests might not be required in certain donor candidates. Measured glomerular filtration rate (GFR) using isotopic methods is more accurate than estimated GFR for the assessment of renal function; however, a new clinical tool might enable the identification of donor candidates for whom nuclear medicine renal scans are not needed. Persistent isolated microscopic haematuria caused by urologic or glomerular diseases can preclude donation and such abnormalities can often be identified by kidney biopsy. Cystoscopy might not be useful for young patients, however, owing to the rarity of urological cancers in this population. Currently, no evidence exists to support the notion that donor candidates at low-risk of cardiac events should undergo additional preoperative cardiovascular evaluation before donation. Reducing and/or eliminating the need for additional testing has the potential to enhance efficiency in the donor evaluation process, improve patient satisfaction, and increase access to living donor kidney transplantation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Recommendations for the renal and cardiac assessment of living kidney donor candidates.

Similar content being viewed by others

References

  1. Segev, D. L. et al. Perioperative mortality and long-term survival following live kidney donation. JAMA 303, 959–966 (2010).

    Article  CAS  Google Scholar 

  2. Lin, J., Kramer, H. & Chandraker, A. K. Mortality among living kidney donors and comparison populations. N. Engl. J. Med. 363, 797–798 (2010).

    Article  CAS  Google Scholar 

  3. Fehrman-Ekholm, I., Elinder, C. G., Stenbeck, M., Tydén, G. & Groth, C. G. Kidney donors live longer. Transplantation 64, 976–978 (1997).

    Article  CAS  Google Scholar 

  4. Lentine, K. L. & Segev, D. L. Understanding and communicating medical risks for living kidney donors: a matter of perspective. J. Am. Soc. Nephrol. 28, 12–24 (2017).

    Article  Google Scholar 

  5. Lam, N. N., Lentine, K. L., Levey, A. S., Kasiske, B. L. & Garg, A. X. Long-term medical risks to the living kidney donor. Nat. Rev. Nephrol. 11, 411–419 (2015).

    Article  Google Scholar 

  6. Delmonico, F. A. Report of the Amsterdam Forum on the care of the live kidney donor: data and medical guidelines. Transplantation 79, S53–S66 (2005).

    Article  Google Scholar 

  7. Andrews, P. A., Burnapp, L., Manas, D., Bradley, J. A. & Dudley, C. Summary of the British Transplantation Society/Renal Association UK guidelines for living donor kidney transplantation. Transplantation 93, 666–673 (2012).

    Article  Google Scholar 

  8. Abramowicz, D. et al. European Renal Best Practice guideline on kidney donor and recipient evaluation and perioperative care. Nephrol. Dial. Transplant. 30, 1790–1797 (2015).

    Article  Google Scholar 

  9. Richardson, R. et al. Kidney paired donation protocol for participating donors 2014. Transplantation 99, S1–S88 (2015).

    Article  Google Scholar 

  10. Tong, A., Chapman, J. R., Wong, G., de Bruijn, J. & Craig, J. C. Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation 92, 962–972 (2011).

    PubMed  Google Scholar 

  11. Lentine, K. L. et al. Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on the evaluation and care of living kidney donors. Transplantation (in press).

  12. Ferriman, A. Becoming a live kidney donor. BMJ 336, 1374–1376 (2008).

    Article  Google Scholar 

  13. Sanner, M. A. The donation process of living kidney donors. Nephrol. Dial. Transplant. 20, 1707–1713 (2005).

    Article  Google Scholar 

  14. Agerskov, H., Ludvigsen, M. S., Bistrup, C. & Pedersen, B. D. Living kidney donors' experiences while undergoing evaluation for donation: a qualitative study. J. Clin. Nurs. 24, 2258–2267 (2015).

    Article  Google Scholar 

  15. LaPointe Rudow, D. et al. Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. Am. J. Transplant. 15, 914–922 (2015).

    Article  CAS  Google Scholar 

  16. Moore, D. R. et al. Living donor kidney transplantation: improving efficiencies in live kidney donor evaluation — recommendations from a consensus conference. Clin. J. Am. Soc. Nephrol. 10, 1678–1686 (2015).

    Article  Google Scholar 

  17. Garg, A. X. et al. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression. Kidney Int. 70, 1801–1810 (2006).

    Article  CAS  Google Scholar 

  18. Kasiske, B. L. et al. A prospective controlled study of living kidney donors: three-year follow-up. Am. J. Kidney Dis. 66, 114–124 (2015).

    Article  Google Scholar 

  19. Fehrman-Ekholm, I. et al. Incidence of end-stage renal disease among live kidney donors. Transplantation 82, 1646–1648 (2006).

    Article  Google Scholar 

  20. Ibrahim, H. N. et al. Long-term consequences of kidney donation. N. Engl. J. Med. 360, 459–469 (2009).

    Article  CAS  Google Scholar 

  21. Cherikh, W. S. et al. Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation. Am. J. Transplant. 11, 1650–1655 (2011).

    Article  CAS  Google Scholar 

  22. Mjøen, G. et al. Long-term risks for kidney donors. Kidney Int. 86, 162–167 (2014).

    Article  Google Scholar 

  23. Muzaale, A. D. et al. Risk of end-stage renal disease following live kidney donation. JAMA 311, 579–586 (2014).

    Article  CAS  Google Scholar 

  24. Lam, N. N., Lentine, K. L. & Garg, A. X. End-stage renal disease risk in live kidney donors: what have we learned from two recent studies? Curr. Opin. Nephrol. Hypertens. 23, 592–596 (2014).

    Article  CAS  Google Scholar 

  25. Rizvi, S. A. H. et al. Long-term safety of living kidney donation in an emerging economy. Transplantation 100, 1284–1293 (2016).

    Article  Google Scholar 

  26. Grams, M. E. et al. Kidney-failure risk projection for the living kidney-donor candidate. N. Engl. J. Med. 374, 411–421 (2016).

    Article  CAS  Google Scholar 

  27. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3, 1–150 (2013).

  28. Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009).

    Article  Google Scholar 

  29. Bhuvanakrishna, T. et al. Comparison of estimated GFR and measured GFR in prospective living kidney donors. Int. Urol. Nephrol. 47, 201–208 (2015).

    Article  CAS  Google Scholar 

  30. Delanaye, P. & Glassock, R. J. Kidney-failure risk projection for the living kidney-donor candidate. N. Engl. J. Med. 374, 2093–2094 (2016).

    Article  Google Scholar 

  31. Lujan, P. R. et al. CKD-EPI instead of MDRD for candidates to kidney donation. Transplantation 94, 637–641 (2012).

    Article  Google Scholar 

  32. Soveri, I. et al. Measuring GFR: a systematic review. Am. J. Kidney Dis. 64, 411–424 (2014).

    Article  Google Scholar 

  33. Stevens, L. A. & Levey, A. S. Measured GFR as a confirmatory test for estimated GFR. J. Am. Soc. Nephrol. 20, 2305–2313 (2009).

    Article  Google Scholar 

  34. Wahba, R. et al. Computed tomography volumetry in preoperative living kidney donor assessment for prediction of split renal function. Transplantation 100, 1270–1277 (2016).

    Article  CAS  Google Scholar 

  35. OPTN/UNOS. Organ Procurement & Transplantation Network Policy 14: living donation. OPTN https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf (2016).

  36. European Renal Best Practice Transplantation Guideline Development Group. ERBP guideline on the management and evaluation of the kidney donor and recipient. Nephrol. Dial. Transplant. 28 (Suppl. 2), ii1–ii71 (2013).

  37. Cohney, S., Kanellis, J. & Howell, M. The CARI guidelines. Donor renal function. Nephrology (Carlton) 15 (Suppl. 1), S137–S145 (2010).

    Article  Google Scholar 

  38. Huang, N. et al. Estimated GFR for living kidney donor evaluation. Am. J. Transplant. 16, 171–180 (2016).

    Article  CAS  Google Scholar 

  39. Gaillard, F. et al. Estimated or measured GFR in living kidney donors work-up? Am. J. Transplant. 16, 3024–3032 (2016).

    Article  CAS  Google Scholar 

  40. Ierino, F. & Kanellis, J. The CARI guidelines. Donors at risk: haematuria. Nephrology (Carlton) 15 (Suppl. 1), S111–S113 (2010).

    Article  Google Scholar 

  41. Jaffe, J. S., Ginsberg, P. C., Gill, R. & Harkaway, R. C. A new diagnostic algorithm for the evaluation of microscopic hematuria. Urology 57, 889–894 (2001).

    Article  CAS  Google Scholar 

  42. Kelly, J. D., Fawcett, D. P. & Goldberg, L. C. Assessment and management of non-visible haematuria in primary care. BMJ 338, a3021 (2009).

    Article  Google Scholar 

  43. Suzuki, Y. et al. Indication of cystoscopy in patients with asymptomatic microscopic haematuria. Scand. J. Urol. Nephrol. 34, 51–54 (2000).

    Article  CAS  Google Scholar 

  44. Hole, B., Whittlestone, T. & Tomson, C. Investigating asymptomatic invisible haematuria. BMJ 349, g6768 (2014).

    Article  Google Scholar 

  45. McGregor, D. O., Lynn, K. L., Bailey, R. R., Robson, R. A. & Gardner, J. Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria. Clin. Nephrol. 49, 345–348 (1998).

    CAS  PubMed  Google Scholar 

  46. Shen, P., He, L., Jiang, Y., Wang, C. & Chen, M. Useful indicators for performing renal biopsy in adult patients with isolated microscopic haematuria. Int. J. Clin. Pract. 61, 789–794 (2007).

    Article  CAS  Google Scholar 

  47. Kido, R. et al. Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy. Am. J. Transplant. 10, 1597–1604 (2010).

    Article  CAS  Google Scholar 

  48. Packham, D. K. Thin basement membrane nephropathy and IgA glomerulonephritis: can they be distinguished without renal biopsy? Nephrology (Carlton) 12, 481–486 (2007).

    Article  CAS  Google Scholar 

  49. Donadio, J. V. & Grande, J. P. IgA nephropathy. N. Engl. J. Med. 347, 738–748 (2002).

    Article  CAS  Google Scholar 

  50. Muzaale, A. D. et al. Outcomes of live kidney donors who develop end-stage renal disease. Transplantation 100, 1306–1312 (2016).

    Article  Google Scholar 

  51. Anjum, S. et al. Patterns of end-stage renal disease caused by diabetes, hypertension, and glomerulonephritis in live kidney donors. Am. J. Transplant. 16, 3540–3547 (2016).

    Article  CAS  Google Scholar 

  52. Tomson, C. R. V. Indications for renal biopsy in chronic kidney disease. Clin. Med. 3, 513–517 (2003).

    Article  Google Scholar 

  53. Koushik, R., Garvey, C., Manivel, J. C., Matas, A. J. & Kasiske, B. L. Persistent, asymptomatic, microscopic hematuria in prospective kidney donors. Transplantation 80, 1425–1429 (2005).

    Article  Google Scholar 

  54. Sobh, M. A., Moustafa, F. E., el- Din Saleh, M. A., Tawfik, A. & Ghoneim, M. A. Study of asymptomatic microscopic hematuria in potential living related kidney donors. Nephron 65, 190–195 (1993).

    Article  CAS  Google Scholar 

  55. Choi, S. R. et al. The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities. Transplant. Proc. 44, 11–13 (2012).

    Article  CAS  Google Scholar 

  56. Hassan, E., Aleid, H., Zulfiquar, T., Ibrahim, I. & Almana, H. Potential kidney donors with asymptomatic microscopic hematuria: histopathological findings & outcomes. Am. J. Transplant. 16 (Suppl. 3), 203–404 (2016).

    Google Scholar 

  57. Schold, J. D. et al. Comorbidity burden and perioperative complications for living kidney donors in the United States. Clin. J. Am. Soc. Nephrol. 8, 1773–1782 (2013).

    Article  Google Scholar 

  58. Schold, J. D. et al. Hospitalizations following living donor nephrectomy in the United States. Clin. J. Am. Soc. Nephrol. 9, 355–365 (2014).

    Article  Google Scholar 

  59. Lentine, K. L. et al. Perioperative complications after living kidney donation: a national study. Am. J. Transplant. 16, 1848–1857 (2016).

    Article  CAS  Google Scholar 

  60. Moody, W. E. et al. Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors? J. Hum. Hypertens. 26, 141–148 (2012).

    Article  CAS  Google Scholar 

  61. Garg, A. X. et al. Cardiovascular disease in kidney donors: matched cohort study. BMJ 344, e1203 (2012).

    Article  Google Scholar 

  62. Reese, P. P. et al. Mortality and cardiovascular disease among older live kidney donors. Am. J. Transplant. 14, 1853–1861 (2014).

    Article  CAS  Google Scholar 

  63. Ierino, F., Boudville, N. & Kanellis, J. The CARI guidelines. Donors at risk: hypertension. Nephrology (Carlton) 15 (Suppl. 1), S114–S120 (2010).

    Article  Google Scholar 

  64. Boudville, N. & Isbel, N. The CARI guidelines. Donors at risk: impaired glucose tolerance. Nephrology (Carlton) 15 (Suppl. 1), S133–S136 (2010).

    Article  Google Scholar 

  65. Isbel, N. The CARI guidelines. Donors at risk: obesity. Nephrology (Carlton) 15 (Suppl. 1), S121–S132 (2010).

    Article  Google Scholar 

  66. Fleisher, L. A. et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J. Am. Coll. Cardiol. 64, e77–e137 (2014).

    Article  Google Scholar 

  67. Lee, T. H. et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100, 1043–1049 (1999).

    Article  CAS  Google Scholar 

  68. Devereaux, P. J. et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 173, 627–634 (2005).

    Article  CAS  Google Scholar 

  69. Dakik, H. A., Kobrossi, S. & Tamim, H. The yield of routine pre-operative cardiovascular evaluation in stable patients scheduled for elective non-cardiac surgery. Int. J. Cardiol. 186, 325–327 (2015).

    Article  Google Scholar 

  70. Taler, S. J. et al. Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am. J. Transplant. 13, 390–398 (2013).

    Article  CAS  Google Scholar 

  71. Hewing, B. et al. Midterm echocardiographic follow-up of cardiac function after living kidney donation. Clin. Nephrol. 83, 253–261 (2015).

    Article  Google Scholar 

  72. Moody, W. E. et al. Cardiovascular effects of unilateral nephrectomy in living kidney donors. Hypertension 67, 368–377 (2016).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

N.N.L. is supported by the Kidney Research Scientist Core Education and National Training Program (KRESCENT) New Investigator award. K.L.L. is supported by a grant from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), “Long-Term Health Outcomes After Live Kidney Donation in African Americans” (R01-DK096008). A.X.G. received an investigator-initiated grant from Astellas to support a Canadian Institutes of Health Research study in living kidney donors, and his institution has received unrestricted research funding from Pfizer. He is supported by the Dr Adam Linton Chair in Kidney Health Analytics.

Author information

Authors and Affiliations

Authors

Contributions

N.N.L. researched the data for the article. All authors contributed substantially to discussion of the article's content, writing, and review or editing the manuscript before submission.

Corresponding author

Correspondence to Ngan N. Lam.

Ethics declarations

Competing interests

A.X.G. has received funding from Astellas, and his institution has received unrestricted research funding from Pfizer. The other authors declare no competing interests.

Related links

PowerPoint slides

Glossary

Revised Cardiac Risk Index

(RCRI). The RCRI includes the following risk factors to assess the risk of perioperative cardiac death, non-fatal myocardial infarction, and non-fatal cardiac arrest: history of ischaemic heart disease, congestive heart failure, cerebrovascular disease, diabetes mellitus requiring insulin, chronic kidney disease (serum creatinine >177 μmol/l (>2 mg/dl)), and high-risk surgery (supra-inguinal vascular, intra-peritoneal, or intra-thoracic surgery).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lam, N., Lentine, K. & Garg, A. Renal and cardiac assessment of living kidney donor candidates. Nat Rev Nephrol 13, 420–428 (2017). https://doi.org/10.1038/nrneph.2017.43

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2017.43

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing